Global seroprevalence of Toxoplasma gondii infection among patients with mental and neurological disorders: A systematic review and meta‐analysis

Abstract Background and Aim Toxoplasmosis is the most widespread zoonotic disease that affects one‐third of the world's population, and imposes a major public health problem worldwide. This study aimed to assess the prevalence of toxoplasmosis among patients with neuropsychiatric patients. Meth...

Full description

Bibliographic Details
Main Authors: Habtye Bisetegn, Habtu Debash, Hussen Ebrahim, Naunian Mahmood, Alemu Gedefie, Mihret Tilahun, Ermiyas Alemayehu, Ousman Mohammed, Daniel Getacher Feleke
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Health Science Reports
Subjects:
Online Access:https://doi.org/10.1002/hsr2.1319
_version_ 1827912679590723584
author Habtye Bisetegn
Habtu Debash
Hussen Ebrahim
Naunian Mahmood
Alemu Gedefie
Mihret Tilahun
Ermiyas Alemayehu
Ousman Mohammed
Daniel Getacher Feleke
author_facet Habtye Bisetegn
Habtu Debash
Hussen Ebrahim
Naunian Mahmood
Alemu Gedefie
Mihret Tilahun
Ermiyas Alemayehu
Ousman Mohammed
Daniel Getacher Feleke
author_sort Habtye Bisetegn
collection DOAJ
description Abstract Background and Aim Toxoplasmosis is the most widespread zoonotic disease that affects one‐third of the world's population, and imposes a major public health problem worldwide. This study aimed to assess the prevalence of toxoplasmosis among patients with neuropsychiatric patients. Methods Electronic databases PubMed, Google Scholar, Web of Science, Research Gate, and Scopus were thoroughly searched from February to March 2022 to identify all relevant studies. The quality of studies was evaluated using the Newcastle−Ottawa quality scale for case‐control and cross‐sectional studies. Statistical analysis was done using STATA version 12 software. A random effect model was used to compute the global pooled seroprevalence of Toxoplasma gondii infection. Heterogeneity was quantified by using I2 value. Subgroup analysis was done, and publication bias was assessed using a funnel plot and Egger's test. Result Of 1250 studies, 49 containing 21,093 participants and conducted in 18 countries were included. The global pooled seroprevalence of T. gondii IgG antibody was 38.27% (95% CI: 32.04−44.9) among neuropsychiatric patients and 25.31% (95% CI: 21.53−29.08) in healthy controls with substantial heterogeneity of 98.3%. The prevalence of T. gondii IgG antibody was higher in males (17.52%) than in females (12.35%) neuropsychiatric patients. The highest pooled prevalence of T. gondii IgG antibody was in Europe (57%) followed by Africa (45.25%) and Asia (43%). Time based analysis showed the highest pooled prevalence of T. gondii IgG antibody in 2012−2016 (41.16%). The global pooled seroprevalence T. gondii IgM antibody among neuropsychiatric patients and healthy controls was 6.78% (95% CI: 4.87−8.69) and 3.13% (95% CI: 2.02−4.24), respectively. Conclusion The pooled prevalence of chronic and acute T. gondii infection among neuropsychiatric patients was 38.27% and 6.78%, respectively. This showed a high burden of toxoplasmosis among neurological and psychiatric patients and urges routine screening of those patients and providing appropriate treatment. It also indicates the need for different stakeholders to develop targeted prevention and control strategies for T. gondii infection.
first_indexed 2024-03-13T02:20:04Z
format Article
id doaj.art-7872018862164846954c5617a75cd071
institution Directory Open Access Journal
issn 2398-8835
language English
last_indexed 2024-03-13T02:20:04Z
publishDate 2023-06-01
publisher Wiley
record_format Article
series Health Science Reports
spelling doaj.art-7872018862164846954c5617a75cd0712023-06-30T10:20:50ZengWileyHealth Science Reports2398-88352023-06-0166n/an/a10.1002/hsr2.1319Global seroprevalence of Toxoplasma gondii infection among patients with mental and neurological disorders: A systematic review and meta‐analysisHabtye Bisetegn0Habtu Debash1Hussen Ebrahim2Naunian Mahmood3Alemu Gedefie4Mihret Tilahun5Ermiyas Alemayehu6Ousman Mohammed7Daniel Getacher Feleke8Department of Medical Laboratory Sciences, College of Medicine and Health Sciences Wollo University Dessie EthiopiaDepartment of Medical Laboratory Sciences, College of Medicine and Health Sciences Wollo University Dessie EthiopiaDepartment of Medical Laboratory Sciences, College of Medicine and Health Sciences Wollo University Dessie EthiopiaDepartment of Zoology University of Sargodha Sargodha PakistanDepartment of Medical Laboratory Sciences, College of Medicine and Health Sciences Wollo University Dessie EthiopiaDepartment of Medical Laboratory Sciences, College of Medicine and Health Sciences Wollo University Dessie EthiopiaDepartment of Medical Laboratory Sciences, College of Medicine and Health Sciences Wollo University Dessie EthiopiaDepartment of Medical Laboratory Sciences, College of Medicine and Health Sciences Wollo University Dessie EthiopiaDepartment of Microbiology, Immunology and Parasitology, College of Health Sciences Addis Ababa University Addis Ababa EthiopiaAbstract Background and Aim Toxoplasmosis is the most widespread zoonotic disease that affects one‐third of the world's population, and imposes a major public health problem worldwide. This study aimed to assess the prevalence of toxoplasmosis among patients with neuropsychiatric patients. Methods Electronic databases PubMed, Google Scholar, Web of Science, Research Gate, and Scopus were thoroughly searched from February to March 2022 to identify all relevant studies. The quality of studies was evaluated using the Newcastle−Ottawa quality scale for case‐control and cross‐sectional studies. Statistical analysis was done using STATA version 12 software. A random effect model was used to compute the global pooled seroprevalence of Toxoplasma gondii infection. Heterogeneity was quantified by using I2 value. Subgroup analysis was done, and publication bias was assessed using a funnel plot and Egger's test. Result Of 1250 studies, 49 containing 21,093 participants and conducted in 18 countries were included. The global pooled seroprevalence of T. gondii IgG antibody was 38.27% (95% CI: 32.04−44.9) among neuropsychiatric patients and 25.31% (95% CI: 21.53−29.08) in healthy controls with substantial heterogeneity of 98.3%. The prevalence of T. gondii IgG antibody was higher in males (17.52%) than in females (12.35%) neuropsychiatric patients. The highest pooled prevalence of T. gondii IgG antibody was in Europe (57%) followed by Africa (45.25%) and Asia (43%). Time based analysis showed the highest pooled prevalence of T. gondii IgG antibody in 2012−2016 (41.16%). The global pooled seroprevalence T. gondii IgM antibody among neuropsychiatric patients and healthy controls was 6.78% (95% CI: 4.87−8.69) and 3.13% (95% CI: 2.02−4.24), respectively. Conclusion The pooled prevalence of chronic and acute T. gondii infection among neuropsychiatric patients was 38.27% and 6.78%, respectively. This showed a high burden of toxoplasmosis among neurological and psychiatric patients and urges routine screening of those patients and providing appropriate treatment. It also indicates the need for different stakeholders to develop targeted prevention and control strategies for T. gondii infection.https://doi.org/10.1002/hsr2.1319global prevalenceneuropsychiatric disorderpsychiatric patientsToxoplasma gondiitoxoplasmosis
spellingShingle Habtye Bisetegn
Habtu Debash
Hussen Ebrahim
Naunian Mahmood
Alemu Gedefie
Mihret Tilahun
Ermiyas Alemayehu
Ousman Mohammed
Daniel Getacher Feleke
Global seroprevalence of Toxoplasma gondii infection among patients with mental and neurological disorders: A systematic review and meta‐analysis
Health Science Reports
global prevalence
neuropsychiatric disorder
psychiatric patients
Toxoplasma gondii
toxoplasmosis
title Global seroprevalence of Toxoplasma gondii infection among patients with mental and neurological disorders: A systematic review and meta‐analysis
title_full Global seroprevalence of Toxoplasma gondii infection among patients with mental and neurological disorders: A systematic review and meta‐analysis
title_fullStr Global seroprevalence of Toxoplasma gondii infection among patients with mental and neurological disorders: A systematic review and meta‐analysis
title_full_unstemmed Global seroprevalence of Toxoplasma gondii infection among patients with mental and neurological disorders: A systematic review and meta‐analysis
title_short Global seroprevalence of Toxoplasma gondii infection among patients with mental and neurological disorders: A systematic review and meta‐analysis
title_sort global seroprevalence of toxoplasma gondii infection among patients with mental and neurological disorders a systematic review and meta analysis
topic global prevalence
neuropsychiatric disorder
psychiatric patients
Toxoplasma gondii
toxoplasmosis
url https://doi.org/10.1002/hsr2.1319
work_keys_str_mv AT habtyebisetegn globalseroprevalenceoftoxoplasmagondiiinfectionamongpatientswithmentalandneurologicaldisordersasystematicreviewandmetaanalysis
AT habtudebash globalseroprevalenceoftoxoplasmagondiiinfectionamongpatientswithmentalandneurologicaldisordersasystematicreviewandmetaanalysis
AT hussenebrahim globalseroprevalenceoftoxoplasmagondiiinfectionamongpatientswithmentalandneurologicaldisordersasystematicreviewandmetaanalysis
AT naunianmahmood globalseroprevalenceoftoxoplasmagondiiinfectionamongpatientswithmentalandneurologicaldisordersasystematicreviewandmetaanalysis
AT alemugedefie globalseroprevalenceoftoxoplasmagondiiinfectionamongpatientswithmentalandneurologicaldisordersasystematicreviewandmetaanalysis
AT mihrettilahun globalseroprevalenceoftoxoplasmagondiiinfectionamongpatientswithmentalandneurologicaldisordersasystematicreviewandmetaanalysis
AT ermiyasalemayehu globalseroprevalenceoftoxoplasmagondiiinfectionamongpatientswithmentalandneurologicaldisordersasystematicreviewandmetaanalysis
AT ousmanmohammed globalseroprevalenceoftoxoplasmagondiiinfectionamongpatientswithmentalandneurologicaldisordersasystematicreviewandmetaanalysis
AT danielgetacherfeleke globalseroprevalenceoftoxoplasmagondiiinfectionamongpatientswithmentalandneurologicaldisordersasystematicreviewandmetaanalysis